APOLLOE4 Phase 3 study of oral ALZ-801/valiltramiprosate in APOE ε4/ε4 homozygotes with early Alzheimer's disease: Trial design and baseline characteristics.

Susan AbushakraAnton P PorsteinssonMarwan SabbaghDavid WatsonAidan PowerEarvin LiangEmer MacSweeneyMerce BoadaSusan FlintRosalind McLaineJ Patrick KesslakJohn A HeyMartin Tolar

Published in: Alzheimer's & dementia (New York, N. Y.) (2024)

ε4/ε4 AD subjects.

Keyphrases

cognitive decline
open label
phase iii
study protocol
phase ii
clinical trial
high fat diet
mild cognitive impairment
placebo controlled
double blind
randomized controlled trial
type diabetes
metabolic syndrome
insulin resistance